{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:26Z","timestamp":1790735906680,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.autrev.2020.102573","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T12:28:24Z","timestamp":1588681704000},"page":"102573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":233,"title":["COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?"],"prefix":"10.1016","volume":"19","author":[{"given":"Serena","family":"Colafrancesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102573_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2020.102573_bb0010","article-title":"Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning","volume":"102538","author":"Shoenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2020.102573_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102573_bb0020","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"105954","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0025","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.4081\/idr.2020.8543","article-title":"National Institute for the Infectious Diseases \u201cL. Spallanzani\u201d, IRCCS. recommendations for COVID-19 clinical management","volume":"12","author":"Nicastri","year":"2020","journal-title":"Infect Dis Rep"},{"issue":"10229","key":"10.1016\/j.autrev.2020.102573_bb0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Manson JJ; HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102573_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","author":"Siddiqi","year":"2020","journal-title":"J Hearth Lung Transpl"},{"key":"10.1016\/j.autrev.2020.102573_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102573_bb0045","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"10229","key":"10.1016\/j.autrev.2020.102573_bb0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102573_bb0055","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China","author":"Zhang","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102573_bb0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","article-title":"New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity","volume":"30","author":"Recalcati","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102573_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2020.102573_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exphem.2005.10.006","article-title":"Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks","volume":"34","author":"Moroz","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.autrev.2020.102573_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0306-9877(95)90075-6","article-title":"Reversal of ferritin-mediated immunosuppression by levamisole: a rationale for its application to management of the acquired immune deficiency syndrome (AIDS)","volume":"44","author":"Wigginton","year":"1995","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2020.102573_bb0080","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/ nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2020.102573_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2020.102573_bb0090","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood-2003-09-3050","article-title":"Regulated secretion of glycosylated human ferritin from hepatocytes","volume":"103","author":"Ghosh","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.autrev.2020.102573_bb0095","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a non-classical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2020.102573_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102573_bb0105","article-title":"A fatal correlation: ferritin as a marker of severity in COVID-19 patients","author":"Dahan","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1039\/C4IB00025K","article-title":"Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases","volume":"6","author":"Pretorius","year":"2014","journal-title":"Integr Biol (Camb)"},{"issue":"9","key":"10.1016\/j.autrev.2020.102573_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jemt.22047","article-title":"Iron enhances generation of fibrin fibers in human blood: implications for pathogenesis of stroke","volume":"75","author":"Lipinski","year":"2012","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.autrev.2020.102573_bb0120","article-title":"COVID-19 as part of hyperferritinemic syndromes: implications for treatment","author":"Perricone","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102573_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study","author":"Deng","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"0","key":"10.1016\/j.autrev.2020.102573_bb0130","article-title":"Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.autrev.2020.102573_bb0135","first-page":"142","article-title":"Adult-onset Still\u2019s disease: not always so good","volume":"30","author":"Priori","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102573_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/TH12-03-0212","article-title":"Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome","volume":"109","author":"Bontadi","year":"2013","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.autrev.2020.102573_bb0155","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","article-title":"The role of infectious diseases in the catastrophic antiphospholipid syndrome","volume":"14","author":"Garcia-Carrasco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102573_bb0160","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102573_bb0165","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"Bridgewood C4. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102573_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2020-206522","article-title":"Autopsy in suspected COVID-19 cases","author":"Hanley","year":"2020","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102573_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2020.102573_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"24","key":"10.1016\/j.autrev.2020.102573_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006656","article-title":"Refractory adult-onset still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8mg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.autrev.2020.102573_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MD.0000000000000112","article-title":"Myocarditis in adult-onset still disease","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102573_bb0195","series-title":"The Royal Collage of Pathologists","article-title":"Autopsy practice relating to possible cases of COVID-19 (2019-nCov, novel coronavirus from China 2019\/2020)","author":"Osborn","year":"2020"},{"key":"10.1016\/j.autrev.2020.102573_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"7047","key":"10.1016\/j.autrev.2020.102573_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102573_bb0210","doi-asserted-by":"crossref","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1753425916671018","article-title":"Environment impacts innate immune ontogeny","volume":"23","author":"Garand","year":"2017","journal-title":"Innate Immun"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195392","article-title":"Interplay of strain and race\/ethnicity in the innate immune response to M. tuberculosis","volume":"13","author":"Nahid","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/vim.2011.0051","article-title":"Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination","volume":"201225","author":"Umlauf","year":"2012","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102573_bb0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbes Infect"},{"issue":"7","key":"10.1016\/j.autrev.2020.102573_bb0235","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"Suppl2","key":"10.1016\/j.autrev.2020.102573_bb0240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2018-eular.3454","article-title":"Identification of rare coding variants in IL-1-related pathways in patients with adult-onset still\u2019s disease","volume":"77","author":"Cavalli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102573_bb0245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms","volume":"7","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2020.102573_bb0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0255","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","article-title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses","volume":"9","author":"Fung","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0260","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2004.08.011","article-title":"Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)","volume":"329","author":"Sainz","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.autrev.2020.102573_bb0270","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0275","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1378\/chest.108.5.1303","article-title":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome","volume":"108","author":"Meduri","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2020.102573_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","author":"Ulhaq","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.autrev.2020.102573_bb0285","doi-asserted-by":"crossref","first-page":"43829","DOI":"10.1038\/srep43829","article-title":"IL-6 ameliorates acute lung injury in influenza virus infection","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102573_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217367","article-title":"To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic","author":"Spinelli","year":"2020","journal-title":"Ann Rheumatic"},{"key":"10.1016\/j.autrev.2020.102573_bb0295","article-title":"First cases of COVID-19 from China","author":"Li","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.autrev.2020.102573_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.03.007","article-title":"COVIID-19: yet another coronavirus challenge in heart transplantation","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.autrev.2020.102573_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102573_bb0310","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-019-2021-9","article-title":"Management of adult-onset Still\u2019s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts","volume":"21","author":"Colafrancesco","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0315","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","article-title":"Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still\u2019s disease: a meta-analysis","volume":"28","author":"Ma","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102573_bb0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102573_bb0325","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the Seattle region - case series","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102573_bb0330","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state","author":"Arentz","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.autrev.2020.102573_bb0335","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:49Z","timestamp":1761599869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722030135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S156899722030135X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102573","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102573"}}